MP-513

· Tanabe Pharma Corporation

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for MP-513, covering 2012-12-19 to 2015-08-28. Get the full timeline:

Most recent: Clinical Trial Update: Long-term Safety Study of MP-513 in Patients With Type 2 Diabetes [Phase 3]